Page 9 - தேசிய மருத்துவ மேலாண்மை ப்ரோடொகால் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India bans Remdesivir exports till COVID surge abates Seven Indian companies producing Remdesivir injections under voluntary licensing agreement with US-based Gilead Sciences have an installed capacity of about 38.80 lakh units per month BusinessToday.In | April 11, 2021 | Updated 18:45 IST India has seven domestic Remdesivir producers India has banned the export of Remdesivir injection and active pharmaceutical ingredients (API) used for making the coronavirus medication till the recent surge in COVID-19 cases subsides. India has been witnessing a surge in COVID-19 cases with the second wave of the pandemic. As of Sunday, the number of active cases stood at 11.08 lakh, and this figure is steadily rising, said the Ministry of Health and Family Welfare. This has led to a sudden spike in demand for Injection Remdesivir used in treatment of COVID patients. There is a potential of further increase in this demand in the coming days, it further added.

Vivek punjDepartment of pharmaceuticalsGilead sciencesUnion health ministryMinistry of healthNational clinical management protocolHealth ministryHealth secretariesInjection remdesivirState health secretariesRemdesivir export bannedDrug remdesivirRemdesivir coronavirusவிவேக் பூஞ்ச்துறை ஆஃப் மருந்துகள்கிலியட் அறிவியல்